Increased biosimilar options in oncology and impact on administrative burden caused by drug switches: Implications of step therapy.
| Autor: | Poole, Stacey, Blakely, L. Johnetta, Schleicher, Stephen Matthew, Dickson, Natalie R. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 10, Vol. 20, p18-18, 10p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|